MedTrace Logo

Early Application of CPAP in Hematologic

NCT00507533 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2009-02-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the use of CPAP in the prevention of acute respiratory failure in neutropenic ( or hematologic malignancy ) patients .CPAP applied preventively in hematological patients with high risk of ARF may reduce:need for intubations and mechanical ventilation, incidence of pneumonia and sepsis,mortality,length of ICU and hospital stay

Conditions

  • Hematologic Disease

Interventions

PROCEDURE

Continuous positive airway pressure

Sponsors & Collaborators

  • Azienda Ospedaliera San Giovanni Battista

    collaborator OTHER

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Squadrone Vincenzo, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2007-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00507533 on ClinicalTrials.gov